"V体育平台登录" Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1
- PMID: 8875917
- DOI: 10.1056/NEJM199611073351901
"V体育安卓版" Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1
Abstract (V体育ios版)
Background: We tested the hypothesis that ovarian cancers associated with germ-line mutations of BRCA1 have distinct clinical and pathological features as compared with sporadic ovarian cancers. VSports手机版.
Methods: We reviewed clinical and pathological data on patients with primary epithelial ovarian cancer found to have germ-line mutations of BRCA1. Survival among patients with advanced-stage cancer and such mutations was compared with that in control patients matched stage, grade, and histologic subtype of the tumors V体育安卓版. A combination of single-strand conformation and sequencing analyses was used to examine the 22 coding exons and intronic splice-donor and splice-acceptor regions of BRCA1 for mutations in pathological specimens. Alternatively, some patients were known to be obligate carriers of the mutant BRCA1 gene because of their parental relationships with documented mutant-gene carriers. .
Results: We identified 53 patients with germ-line mutations of BRCA1. The average age at diagnosis was 48 years (range, 28 to 78). Histologic examination in 43 of the 53 patients showed serous adenocarcinoma. Thirty-seven tumors were of grade 3, 11 were of grade 2, 2 were of grade 1, and 3 were of low malignant potential. In 38 patients, the tumors were of stage III; 9 patients (including those with tumors of low malignant potential) had stage I disease, 5 had stage IV, and 1 had stage II. As of June 1996, with a median follow-up among survivors of 71 months from diagnosis, 20 patients had died of ovarian cancer, 27 had no evidence of the disease, 4 were alive with the disease, and 2 had died of other diseases. Actuarial median survival for the 43 patients with and advanced-stage disease was 77 months, as compared with 29 months for the matched controls (P<0. 001) V体育ios版. .
Conclusions: As compared with sporadic ovarian cancers, cancers associated with BRCA1 mutation appear to have a significantly more favorable clinical course. VSports最新版本.
"VSports手机版" Comment in
-
"V体育平台登录" Genetics in clinical cancer care--the future is now.N Engl J Med. 1996 Nov 7;335(19):1455-6. doi: 10.1056/NEJM199611073351908. N Engl J Med. 1996. PMID: 8875924 No abstract available.
-
BRCA1 mutations and survival in women with ovarian cancer.N Engl J Med. 1997 Apr 24;336(17):1254; author reply 1256-7. doi: 10.1056/NEJM199704243361713. N Engl J Med. 1997. PMID: 9121519 No abstract available.
-
BRCA1 mutations and survival in women with ovarian cancer.N Engl J Med. 1997 Apr 24;336(17):1254-5; author reply 1256-7. N Engl J Med. 1997. PMID: 9121520 No abstract available.
-
BRCA1 mutations and survival in women with ovarian cancer.N Engl J Med. 1997 Apr 24;336(17):1255; author reply 1256-7. N Engl J Med. 1997. PMID: 9121521 No abstract available.
-
BRCA1 mutations and survival in women with ovarian cancer.N Engl J Med. 1997 Apr 24;336(17):1255; author reply 1256-7. N Engl J Med. 1997. PMID: 9121522 No abstract available.
-
BRCA1 mutations and survival in women with ovarian cancer.N Engl J Med. 1997 Apr 24;336(17):1255-6; author reply 1256-7. N Engl J Med. 1997. PMID: 9121523 No abstract available.
-
BRCA1 mutations and survival in women with ovarian cancer.N Engl J Med. 1997 Apr 24;336(17):1256; author reply 1256-7. N Engl J Med. 1997. PMID: 9121524 No abstract available.
MeSH terms
- "VSports手机版" Actions
- Actions (VSports最新版本)
- "V体育ios版" Actions
- "VSports app下载" Actions
- Actions (V体育2025版)
- "VSports app下载" Actions
- V体育平台登录 - Actions
- "V体育官网入口" Actions
- VSports手机版 - Actions
- VSports注册入口 - Actions
- Actions (V体育平台登录)
- Actions (V体育平台登录)
LinkOut - more resources
Full Text Sources (V体育ios版)
Other Literature Sources
Medical
Research Materials
V体育官网 - Miscellaneous